⌘K

Login Start Free

Home/Filings/4/0001214659-23-016106

4//SEC Filing

Hamm John M. 4

Accession 0001214659-23-016106

CIK 0001087294other

View on SEC.gov Company Profile

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 5:05 PM ET

Size

4.5 KB

Accession

0001214659-23-016106

Insider Transaction Report

Form 4

Period: 2023-11-27

CUMBERLAND PHARMACEUTICALS INCCPIX

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2023-11-27$1.67/sh−352$588→ 26,448 total

Documents

1 file

4
marketforms-63729.xmlPrimary
PRIMARY DOCUMENT

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001870439

Filing Metadata

Form type: 4
Filed: Dec 5, 7:00 PM ET
Accepted: Dec 6, 5:05 PM ET
Size: 4.5 KB

View on SEC.gov